» Articles » PMID: 8675083

Local Entrapment of Interferon Gamma in the Recovery from Shigella Dysenteriae Type 1 Infection

Overview
Journal Gut
Specialty Gastroenterology
Date 1996 Mar 1
PMID 8675083
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

In healthy controls (n = 8) living in shigella endemic areas, accumulation of interferon gamma (IFN gamma) in the epithelial lining was seen in the rectal tissues. At the single cell level, however, few or no IFN gamma protein producing cells or mRNA expressing cells were detected at that site indicating the involvement of the whole large intestine in the production of IFN gamma in controls. Persistent numbers of IFN gamma producing cells were detected in the rectum of patients with Shigella dysenteriae type 1 infection (n = 8) throughout the course of disease with a tendency to increase in the convalescent stage. A significantly increased extra cellular deposition of secreted IFN gamma in tissue was seen in convalescence when compared with the acute stage (p < 0.05). In addition, enzyme immunoassay showed increased stool concentration of IFN gamma in patients at the convalescent stage as well as in healthy controls. In situ hybridisation confirmed the results by showing increased frequency of IFN gamma mRNA containing cells at the late stage of the disease (p < 0.05). Extensive message for IFN gamma was evident in cells in the lamina propria with no detectable transcripts in the surface epithelium. A colocalisation of IFN gamma with the IFN gamma receptor expression, predominantly found in the epithelial lining was detected by immunohistochemistry. Semiquantitative evaluation by computerised image analysis showed a gradual increased expression of IFN gamma and its corresponding receptor in the convalescent stage of shigellosis. This suggested progressive entrapment and binding of IFN gamma to its specific receptor at the local site. The enhanced surface expression of IFN gamma receptor evident at the convalescent stage of shigellosis was comparable to the constitutive level of expression in the healthy subjects. Thus, immunity to shigellosis correlated to up-regulation of IFN gamma production and expression of IFN gamma receptor.

Citing Articles

Determinants of immune responses predictive of protection against shigellosis in an endemic zone: a systems analysis of antibody profiles and function.

Bernshtein B, Kelly M, Cizmeci D, Zhiteneva J, Macvicar R, Kamruzzaman M Lancet Microbe. 2024; 5(10):100889.

PMID: 39116906 PMC: 11488819. DOI: 10.1016/S2666-5247(24)00112-5.


Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development.

Mani S, Toapanta F, McArthur M, Qadri F, Svennerholm A, Devriendt B Vaccine. 2019; 37(34):4787-4793.

PMID: 31230883 PMC: 7413037. DOI: 10.1016/j.vaccine.2019.03.040.


T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans.

Toapanta F, Bernal P, Kotloff K, Levine M, Sztein M J Transl Med. 2018; 16(1):61.

PMID: 29534721 PMC: 5851169. DOI: 10.1186/s12967-018-1439-1.


A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.

Davis C, Wahid R, Toapanta F, Simon J, Sztein M PLoS One. 2018; 13(1):e0189571.

PMID: 29304144 PMC: 5755796. DOI: 10.1371/journal.pone.0189571.


Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.

Chitradevi S, Kaur G, Uppalapati S, Yadav A, Singh D, Bansal A Cell Mol Immunol. 2015; 12(6):757-67.

PMID: 25640657 PMC: 4716628. DOI: 10.1038/cmi.2014.86.


References
1.
Gray P, Leung D, Pennica D, Yelverton E, Najarian R, Simonsen C . Expression of human immune interferon cDNA in E. coli and monkey cells. Nature. 1982; 295(5849):503-8. DOI: 10.1038/295503a0. View

2.
Tesh V, Ramegowda B, Samuel J . Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun. 1994; 62(11):5085-94. PMC: 303229. DOI: 10.1128/iai.62.11.5085-5094.1994. View

3.
Perdomo O, Cavaillon J, Huerre M, Ohayon H, Gounon P, Sansonetti P . Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med. 1994; 180(4):1307-19. PMC: 2191671. DOI: 10.1084/jem.180.4.1307. View

4.
Raqib R, Lindberg A, Wretlind B, Bardhan P, Andersson U, Andersson J . Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun. 1995; 63(1):289-96. PMC: 172990. DOI: 10.1128/iai.63.1.289-296.1995. View

5.
Redl H, Schlag G, Adolf G, Natmessnig B, Davies J . Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia. Infect Immun. 1995; 63(1):297-300. PMC: 172991. DOI: 10.1128/iai.63.1.297-300.1995. View